Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 24:14:1276279.
doi: 10.3389/fimmu.2023.1276279. eCollection 2023.

Editorial: New therapeutic approaches for SARS-CoV-2/COVID-19

Alfonso J Rodriguez-Morales  1   2 , Alexandre Naime Barbosa  3 , Sergio Cimerman  4
Affiliations
Editorial

Editorial: New therapeutic approaches for SARS-CoV-2/COVID-19

Alfonso J Rodriguez-Morales et al. Front Immunol. .
No abstract available

Keywords: COVID-19; SARS-CoV-2; coronavirus; emerging; emerging infectious diseases; global health; pandemic; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
(A) COVID-19 global situation of cases, according to the WHO (https://covid19.who.int/). (B) Genomic distribution clades, lineages and variants of SARS-CoV-2 during 2020-2023 by GISAID (https://gisaid.org/).
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic New therapeutic approaches for SARS-CoV-2/COVID-19

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med (2020) 382(8):727–33. doi: 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
    1. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. . Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis (2020) 34:101623. doi: 10.1016/j.tmaid.2020.101623 - DOI - PMC - PubMed
    1. Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, et al. . Further implications on the global real-world vaccine effectiveness against SARS-CoV-2. Expert Rev Vaccines (2022) 21(9):1355–7. doi: 10.1080/14760584.2022.2110073 - DOI - PubMed
    1. Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, et al. . Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expert Rev Vaccines (2023) 22(1):1–16. doi: 10.1080/14760584.2023.2143347 - DOI - PubMed
    1. Cimerman S, Chebabo A, Cunha CAD, Rodriguez-Morales AJ. Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil. Braz J Infect Dis (2020) 24(2):93–5. doi: 10.1016/j.bjid.2020.04.005 - DOI - PMC - PubMed

Publication types